Invesco’s iBio IBIO Stock Holding History

Invesco’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-119	Closed	-$25K	–	4084
2022 Q1	$25K	Sell	119 -3	-2%	-$628	﹤0.01%	3977
2021 Q4	$33K	Sell	122 -14	-10%	-$5.34K	﹤0.01%	4008
2021 Q3	$72K	Buy	136 +23	+20%	+$14.3K	﹤0.01%	3977
2021 Q2	$85K	Sell	113 -60	-35%	-$43.8K	﹤0.01%	3913
2021 Q1	$133K	Buy	173 +72	+71%	+$62.7K	﹤0.01%	3729
2020 Q4	$53K	Buy	+101	New	+$82.3K	﹤0.01%	3737

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco's IBIO Position: Q2 2022 in Review

Invesco sold out of iBio (IBIO) in Q2 2022, closing a stake of 119 shares — an estimated $25K sold.

Invesco first reported a position in IBIO in Q4 2020 and held it in 6 quarters. The position peaked at $133K in Q1 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

Invesco reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
Invesco sold 119 iBio shares in Q2 2022, an estimated $25K.
Invesco first reported a position in iBio in Q4 2020 and held it in 6 quarters.
Invesco's iBio position peaked at $133K in Q1 2021.
53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.